Do Analysts Expect Atara Biotherapeutics Inc (ATRA) Stock to Rise After It Has Fallen -11.25% in a Month?

Analysts who follow Atara Biotherapeutics Inc (ATRA) on average expect it to climb 454.93% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns Atara Biotherapeutics Inc an Analyst Ranking of 5, which means it ranks higher than 5 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating ATRA a Hold today. Find out what this means to you and get the rest of the rankings on ATRA!

See Full ATRA Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Atara Biotherapeutics Inc Stock Today?

Atara Biotherapeutics Inc (ATRA) stock is trading at $0.71 as of 1:19 PM on Thursday, Mar 28, an increase of $0.01, or 0.87% from the previous closing price of $0.70. The stock has traded between $0.65 and $0.72 so far today. Volume today is low. So far 721,187 shares have traded compared to average volume of 2,222,994 shares. Click Here to get the full Stock Report for Atara Biotherapeutics Inc stock.